In NSCLC, chronic exposure to gemcitabine drastically upregulates Notch3 expression by tumor cells, whereas the addition of DAPT sensitized cell lines to the pyrimidine analogue, affecting pro- and anti-apoptotic protein expression patterns [586]. This evidence concerns the gene NOTCH3 and neoplasm.